Title : p53 polymorphic variants at codon 72 and the outcome of therapy in randomized breast cancer patients.

Pub. Date : 2006 May

PMID : 16609366






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 CONCLUSION: The present report indicates that the codon 72 polymorphism in the p53 gene may be a predictor of tamoxifen response, suggesting that breast cancer patients lacking the Pro72 allele might be candidates for other therapies. Tamoxifen tumor protein p53 Homo sapiens